A wide variety of similar pharmaceutical lawsuits have been filed against a number of pharmaceutical companies related to other products that have been shown to be a hazard to select patients who received those drugs.
The specific damage sustained by users of pph may not yet be apparent, as the pharmaceutical lawsuits related to the use of this drug combination will likely continue for some time.
The number and size of monetary awards facilitated by pph lawyer and pharmaceutical lawsuits related to damages have crippled the makers of the pph component fenfluramine shown to be responsible for personal injuries.
This has forced this company to make a number of changes with respect to anticipated mergers and diversification, and resulted in the liquidation of various assets in order to pay for individual settlements or to establish and maintain a fund designed to compensate individuals who are part of a group named in class action suits.
Should the company survive, it is hoped that the financial hardship related to compensation for medical costs, lost earnings and pain and suffering, as well as those related to punitive damages, will lead to redefined practices in the future.
Call Nick Johnson at 1-888-311-5522 or visit http://www.jbclawfirm.com for a free case evaluation.